TrialThe Lancet. Oncology2019

Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.

Mark T Drayson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.